The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

PRUDENT INVESTORS PAY ATTENTION TO POTENTIAL TRIPLE TOP IN TECH STOCKS

November 11, 2020

To gain an edge, this is what you need to know today. Potential Triple Top Concern Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The chart shows a potential triple top. The chart shows that yesterday on good news about the vaccine, Nasdaq was rejected right at the resistance line.  This is a negative. The chart shows that yesterday after the rejection, Nasdaq closed near its lows. This is a negative. The chart shows that Nasdaq is gapping down.  This is a negative. Nasdaq is gapping down while Dow Jones Industrial Average (DJIA) futures

Read More »

SPIRIT AEROSYSTEMS HOLDINGS: OVER 60% GAIN ON THIS AEROSPACE COMPANY IN A SHORT TIME

November 10, 2020

  Spirit AeroSystems Holdings (SPR) signal was given on October 16.  The average price based on scaling in per the Trade Management Guidelines is about $18.20.  It is trading at $29.28 as of this writing.  Consider taking partial profits on a 10% tranche in the zone of $28.58 to $31.43. Raising the target on the remaining to $36 to $43.  There is potential for the target to be raised further. A special note for new subscribers: In ZYX Method, it is important to always be booking some gains while letting some gains run.  The market is likely to be volatile.  Unrealized

Read More »

TAKE PROFITS ON MARVELL TECHNOLOGY AND EXIT THE POSITION

November 9, 2020

The semiconductor company Marvell Technology Group (MRVL) was bought at $35.33 eight trading days ago.  Partial profits have already been taken. MRVL traded as high as $45.82 on Friday.  The low band of the medium-term target was $46.  Since the gains happened in a very short time, consider taking profits in the zone of $42.75 to $46 and exit the position. Consider entering it again if it dips into the buy zone. This post was just published on ZYX Buy Change Alert. A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO

Read More »

VERY EFFECTIVE COVID-19 VACCINE — HERE IS THE GAME PLAN FOR PRUDENT INVESTORS NOW

November 9, 2020

To gain an edge, this is what you need to know today. Reduce Cash And Hedges Both cash and hedge levels are being reduced.  It is best to make the transition in several steps — some now and more on the dips. Vaccine Vaccine data from Pfizer (PFE) and BioNTech (BNTX) has shown 90% efficacy.  FDA has been willing to approve efficacy of 50%.  Most expectations have been for efficacy of less than 70% The news is much better than expected. Many hurdles still remain. Breakout Above The Magnet  Please click here for a chart of S&P 500 ETF (SPY)

Read More »

NEW BUY ZONES ON 39 STOCKS — WITH BUY ZONES YOU COULD HAVE DOUBLED YOUR MONEY IN APPLE IN FOUR MONTHS

November 8, 2020

Buy zones are very powerful. When a stock dips into the buy zone you buy it.  If you were following the buy zones, you could have more than doubled your money in Apple (AAPL) stock.  Earlier in  2020, Apple dipped into the buy zone as low as $53.01. Since then Apple stock has traded  as high as $137.98.   This represents a return of 160% in a matter of months. With the help of buy zones, you could have bought Microsoft (MSFT) stock as low as $132.52 . Since then Microsoft stock has traded as high as $232.86. Please click here

Read More »

SPECTACULAR JOBS CREATION, TRUMP AND GEORGIA MAY GET IN THE WAY

November 7, 2020

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section ‘Protection Bands and What To Do Now.’ SPECTACULAR JOBS CREATION, TRUMP AND GEORGIA MAY GET IN THE WAY November 6, 2020 To gain an edge, this is what you need

Read More »

BIDEN STOCK MARKET RALLY — FED READY TO PRINT MORE MONEY

November 6, 2020

To gain an edge, this is what you need to know now. The Chart Please click here for a chart of S&P 500 ETF (SPY) which represents stock market benchmark index (SPX). Note the following: The chart shows the big stock market rally in the morning to celebrate the potential Biden victory. The rally was in line with the move up earlier in futures. Before going further, take another look at the magnet that traders are drawn to shown in the chart here.  For details read the Morning Capsule. The VUD indicator is the most sensitive measure of net supply

Read More »

A NEW PROMISING DRUG FOR ALZHEIMER’S — OPPORTUNITY FOR INVESTORS

November 5, 2020

Alzheimer’s Alzheimer’s is a terrible disease.  A new patient is diagnosed with Alzheimer’s in the United States every 65 seconds.  More than 5.8 million Americans are living with Alzheimer’s.  For those who are over 65, one in 10 has Alzheimer’s dementia. There is no cure.  Now a new treatment is on the horizon. If the treatment works, can you imagine the investment potential? New Drug FDA Advisory Committee panel sees ‘substantial evidence’ for approval of Alzheimer’s drug from Biogen (BIIB). BIIB is in the Arora Report Portfolio. We previously wrote: If the drug ultimately works and is approved, BIIB may ultimately

Read More »

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

Skip to content